1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > CRO Quality Benchmarking – Phase II/III Service Providers (8th edition)

CRO Quality Benchmarking – Phase II/III Service Providers (8th edition)

  • July 2016
  • -
  • Industry Standard Research
  • -
  • 179 pages

ISR’s “CRO Quality Benchmarking – Phase II/III Service Providers” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied performance ratings based on their own experiences with 44 Phase II/III CROs, making this report the most comprehensive assessment of CRO service quality in the industry. Now in its 8th year, this report has become a crucial tool for sponsors looking to select a Phase II/III CRO and for service providers seeking an experience-based evaluation of their strengths and weaknesses.

How you can use this report
STUDY SPONSORS
- Make a more informed purchase of Phase II/III services by understanding which service providers best fit your company’s needs
- Broaden your Phase II/III CRO evaluation list by accessing peer-based service quality ratings across 26 critical attributes
- Pinpoint potential delivery concerns early in a sponsor- CRO relationship/ evaluation in order to develop proactive strategies to address potential gaps

CLINICAL SERVICE PROVIDERS
- Uncover your own - and competitor - delivery strengths and weaknesses
- Design messaging to tout your company’s strengths
- Compete more effectively by understanding buyers’ selection criteria and outsourcing trends

FOR PHARMA
Make a more informed purchase of Phase II/III CRO services by understanding which service providers best fit your company’s needs.

FOR CROS
Uncover your perceived strengths and weaknesses based on customer reviews, and compare your services to those of your competitors.

Table Of Contents

CRO Quality Benchmarking - Phase II/III Service Providers (8th edition)
COPYRIGHT AND USAGE
GUIDELINES
INTRODUCTION
METHODOLOGY
RESPONDENT DEMOGRAPHICS AND QUALIFICATIONS
Participant Years of Industry Experience
Participant Geography
Participant Company Size
NUMBER OF RATINGS PER COMPANY
5 MAJOR SECTIONS
SERVICE PROVIDER SELECTION PROCESS
Primary Section Takeaways
Figure 1 - Preferred Provider Agreements
Figure 2 - Selection Attributes
SERVICE PROVIDER PERCEPTIONS AND INTERACTIONS
Primary Section Takeaways
Figure 3 - Phase II/III Leadership, Familiarity, and Use
Figure 4 - Service Provider Preference
Figure 5 - Service Provider Preference Differences by Size
Figure 6 - Cost Experience among Users
Figure 7 - Summary Table
SERVICE PROVIDER
PERFORMANCE AND LOYALTY
Primary Section Takeaways
Figure 8 - Budget Factors
Figure 9 - Delivery Factors
Figure 10 - Organization Factors
Figure 11 - Staff Characteristics
Figure 12 - Timelines Management
Figure 13 - Customer Loyalty: 2016
Figure 14 - Customer Loyalty: 3 Year Rolling Average
COMPANY SERVICE QUALITY PROFILES
Accenture
BioClinica
Chiltern
Cognizant
Covance
DCRI-Duke
Eurofins
ICON
INC Research
inVentiv Health Clinical
Medpace
PAREXEL
PPD
PRA
Premier Research
Quintiles
SGS Life Sciences
SynteractHCR
Tata
Theorem
TKL Research
Worldwide Clinical Trials
STUDY DATA
Phase II/III Leaders, Unprompted
Phase II/III Leaders, Prompted
Service Provider Familiarity
Service Provider Usage
Service Provider Preference
Service Provider Differentiation
Selection Drivers: Selecting among Preferred Providers
Preferred Provider Attributes Gaining Importance
Selection Drivers When Not Using Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance: No Preferred Providers
Service Provider Cost Perceptions
Use of Preferred Providers
Number of Preferred Providers
Service Provider Drill-downs
Accell
Accelovance
Accenture
BioClinica
Bioskin
Chiltern
Clinical Research Services
(CRS)
Clinipace
Clinlogix
Clinsys
Cognizant
Covance
DaVita Clinical Research
DCRI - Duke
Encorium
Eurofins
Eurotrials
Frontage
ICON
Inamed
INC Research
inVentiv Health Clinical
KCR
Lambda
Medpace
Medsource
NAMSA
Novotech
PAREXEL
Pharm-Olam International
PPD
PRA
Premier Research
ProTrials
QPS
Quintiles
Rho
SGS Life Sciences
Symbio
SynteractHCR
Tata
Theorem
TKL Research
Worldwide Clinical Trials
Performance Across Service
Providers
DEMOGRAPHICS
Company Type
Headquarters Location
Office Location
Job Title
Decision-making
Responsibility
Outsourcing Involvement by
Phase
Involvement in Clinical
Development
Therapeutic Areas of
Responsibility
Years of Industry Experience
Age
ABOUT INDUSTRY STANDARD
RESEARCH

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
HPLC Markets: Global Analysis and Opportunity Evaluation 2016 - 2020

HPLC Markets: Global Analysis and Opportunity Evaluation 2016 - 2020

  • $ 5800
  • Industry report
  • October 2016
  • by Laboratory Markets Limited

This market report provides a comprehensive and easy-to-review analysis of the analytical HPLC market 2016 to 2020, providing key market data and identifying new and emerging opportunities across this ...

Label-free Array Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Label-free Array Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Label-free Array Systems: Overview Label-free array systems are used in the drug discovery industry by pharmaceutical and biotechnology companies, and work on the principles of optical interferometry, ...

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.